MedDataX Logo

Optimizing Fidelity to Family-Based Treatment for Adolescent Anorexia Nervosa

NCT ID: NCT02139462

Last Updated: 2017-10-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

47 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-05-31

Study Completion Date

2017-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will use a data base of archived therapy sessions of family therapy for adolescent anorexia nervosa to determine the role of fidelity to treatment and outcome. In addition, it will develop a novel, more efficient way to train therapists in family therapy for adolescent anorexia nervosa and examine if it is feasible to conduct a trial comparing this novel training to standard, more intensive training.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Online Training for Therapists

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard training

Therapists will receive standard training in FBT.

Group Type EXPERIMENTAL

Standard FBT training

Intervention Type OTHER

Therapists will receive standard training in Family Based Treatment (FBT)

Novel training

Therapists will receive a novel, more efficient training in FBT

Group Type EXPERIMENTAL

Novel FBT training

Intervention Type OTHER

Therapists will receive a novel training in Family Based Treatment (FBT)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard FBT training

Therapists will receive standard training in Family Based Treatment (FBT)

Intervention Type OTHER

Novel FBT training

Therapists will receive a novel training in Family Based Treatment (FBT)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* masters or doctoral training in their field (psychology, psychiatry, family therapy).
* must be licensed
* have no reports of malpractice or loss of privileges at clinical institution
* minimum caseload 5 adolescents with AN each year over past 3 years
* no previous training in FBT
* computer/web access

Exclusion Criteria

* Previous FBT training for AN
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

James Dale Lock

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James Lock, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Daniel Le Grange, PhD

Role: PRINCIPAL_INVESTIGATOR

University of California, San Francisco

W. Stewart Agras, MD

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University

Stanford, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SPO 103420

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

1R21MH096779-01

Identifier Type: NIH

Identifier Source: org_study_id

View Link